 |
 |
 |
|
The
HIV/AIDS eNews is published by the British Columbia Persons With AIDS
Society. This publication is a compilation of various articles
collected from numerous news sources. Opinions and information
expressed are those of the individual authors and not necessarily those
of the Society.
|
|
|
|
AccolAIDS 2009
Join us for the 8th annual AccolAIDS Award Gala and Auction. Hosted by Symone, Vancouver's First Lady of Glam.
When: Sunday April 19th, 6PM-10PM
Where: Pacific Ballroom at the Fairmont Hotel, Vancouver.
Tickets $150 each or $1200 for a table of 8.
Click here for more info. |
|
|
|
|
BC's Big Opt Out
BC’s Big Opt Out urges British Columbians to protect their right to privacy by refusing their personal health information be subject to eHealth, the BC Government’s new system of integrated electronic health records.
Visit their website www.bcoptout.ca to learn more about eHealth and what you can do about it. |
|
|
VOLUNTEER RECEPTION
BCPWA invites our volunteers to the South Pacific: A Night in the Tropics! This year's volunteer appreciation party is all about grass skirts, songs and sarongs.
When: 6-9.30pm, Thursday April 30
Where: Holiday Inn & Suites (1110 Howe at Helmcken)
Tickets: $10 deposit for volunteers, $25 flat-rate for friends of volunteers.
For more information, contact Marc at 604.893.2298 or marcs@bcpwa.org |
|
|
|
WEDNESDAY NIGHT SUPPORT GROUP
The Wednesday evening group welcomes people living
with HIV disease, people who are co-infected with Hepatitis C, as well
as family, friends, medical or social supports of group members. The
group focuses on mutual support, empowerment, and information exchange.
Date: Every Wednesday Evening
Time: 7:00pm - 9:00pm
Location: The Lounge - 2nd Floor
Address:1107 Seymour Street, Vancouver |
|
|
For more info, click here, or call 604.893.2259.
|
HEALING RETREAT
Healing retreats for HIV-positive men and women. Join HIV-positive
people from all walks of life. Meet new friends and learn more about
yourself.
Date: June 26 - 29, 2009 and September 4 - 7, 2009
Location: Loon Lake [ Map ]
Registration: Register at reception
To book an interview:
Phone: 604.893.2200
Toll Free: 1.800.994.2437 ext. 200 |
|
|
For more info, click here.
|
Do You Need Better Access to Information on HIV/AIDS Treatment?
Then participate in a survey!
You can help BCPWA by participating in a research project to assess the changing treatment information needs of HIV-positive people in BC. The research examines the experiences that HIV-positive people have with access to HIV/AIDS treatment information and the quality of these experiences.
To access the questionnaire, go to:
http://infopoll.net/live/surveys/s33258.htm |
|
Some Changes and Updates
INCOME TAX RETURNS
February 25, 2009 through April 15th 2009. Sign up at Front Desk or call 604-893-2200. |
 |
POLLI & ESTHER'S CLOSET
Now by appointment only.
Members are allowed one visit per month. |
|
|
FitOne - An Introduction to Active Living
Designed for individuals seeking a more active lifestyle, FitOne aims to educate participants about the beneficial effects of exercise on HIV disease while creating a mutually supportive and motivating environment.
Intended for all fitness levels, a certified kinesiologist will assess and design programs suited for individual needs. Yoga mats and exercise equipement provided. Comfortable cloths and exercise shoes recommended. Beginners welcome.
Activities may include group walks, running clinics, and beginner's yoga. |
 |
Weekly sessions begin Wednesday, February 25, 2009 from 3 – 4pm in the BCPWA Training Room
For more information, please contact elginl@bcpwa.org or call 604.893-2225. Limited number of participants. Register now. |
|
|
AmBigYouUs
Are you HIV+ and Trans? Join us at AmBigYouUs, a monthly mingling and networking event specifically for the HIV+ Trans community.
Where: BCPWA's Training Room (1st Floor)
When: First Wednesday of the month, 6-8pm
For more information, please call 604.893.2258 |
|
|
|
SPIRITUAL WORKSHOP
Non-denominational, supportive, unique and fun.
Join other HIV+ men and women, lakeside at the Bethlehem Retreat Centre on Vancouver Island for a 3-night/ 4 day workshop devoted to personal spirituality. A provocative, progressive workshop created on the teachings of Mathew Fox. People come away renewed with a sense of hope, a feeling of global community and a boost to their self-esteem.
|
|
Workshop designed and facilitated by United Church Ministers, Rev. Tim Stevenson, and spouse Rev. Gary Paterson, Minister St. Andrew's Wesley United Church. Taking time to laugh and to listen, their knowledge and kindness enhances learning and garners trust.
Organized by BCPWA Retreat Team.
Lodging and meal hosted by the Benedictine Sisters.
Transportation provided.
Spaces go quickly.
Interviews March 2-April 10, 2009.
Register for an interview 604.893.2200 or 1.800.994.2437. |
|
|
|
 |
Survey on Employment Issues for People Living with HIV/AIDS
People living with HIV are invited to participate in an online survey on HIV and employment in Canada. The purpose of this survey is to learn more about the education, training, employment and health needs of people living with HIV. Our ultimate goal is a national network that will provide employment support, information and advocacy opportunities for people living with HIV whether in or out of the workforce. Your responses to the survey will inform us on the employment-related issues that matter to you most.
The survey is available electronically and will take approximately 25 minutes to complete. You will be able to save survey responses and then submit the final version at a later date. If you would like to request a hardcopy of the survey please send your contact information to the address below.
You do not have to give personal information and we do not plan to publish personal information. If this plan changes, we will only do so with your agreement. You have the right to opt out of any question(s) at any point throughout the survey. You may choose to provide us with contact information if you would like to be kept updated on the progress of this project.
The link to the survey is provided below. The survey will be open for responses through Friday, March 13. This opportunity is unique to people with HIV. We look forward to your response to the survey.
http://www.surveymonkey.com/s.aspx?sm=BxPMtNFSCtrk5n1CZTiWPQ_3d_3d
|
Victoria man gets 10 years in prison in HIV sex-assault case
Musician failed to tell four women he was HIV positive; one has been infected
March 31, 2009
A
member of a popular Victoria marimba band has been sentenced to 10
years less three days for having unprotected sex with four Greater
Victoria women without telling them he was HIV positive.
On
March 2, Charles Kokanai Mzite, 37, was convicted of four counts of
aggravated sexual assault between May 2001 and November 2005. Today,
B.C. Supreme Court Justice Robert Johnston told Mzite he had committed
offences that could only be described as “profoundly selfish.”
“You
infected one woman and exposed three others to very serious risk to
satisfy your own needs for intimacy and sexual gratification,” said
Johnston.
“Each of the complaints would have refused to have
sexual intercourse with Mr. Mzite if she’d known he was HIV positive.
Each of the cases occurred in the context of a relationship. ... Each
of the victims felt safe because he denied he was HIV positive.”
Johnston
sentenced Mzite to four years for the woman he infected with HIV, the
virus that causes AIDS, and two years less a day for each of his other
three victims. The sentences are to be served consecutively.
Mzite,
who was been in custody since September 2007, was credited with 37.5
months time served. This means he must serve a further six years and 10
months in prison.
Mzite, a dancer and musician who used to
perform with the Jambanja group on the streets of downtown Victoria,
must also comply with the National Sex Offender Registry and provide a
DNA sample. The judge did not impose a weapons prohibition as requested
by Crown prosecutor Nils Jensen.
Defence lawyer Martin Allen indicated to the court that his client might appeal his conviction.
Mzite,
who appeared in court with his head shorn, chose not to address the
court before Johnston passed sentence upon him. He sat impassive,
slumped in a corner of the prisoners’ dock. None of his victims were
present in the courtroom.
Johnston acknowledged the sentence
will affect Mzite’s immigration status. Mzite came to Canada from
Zimbabwe in 2001. He has been a convention refugee since his
application was accepted in 2001 and is a protected person under the
Immigration and Refugee Act.
“I have evidence, that as a result
of these convictions, Mr. Mzite will, in all likelihood, be ordered
deported from Canada,” said Johnston.
Although, with a sentence
of four years, Mzite has lost his right of appeal to the Immigration
Appeal Board, he will not be deported automatically, said Johnston. As
a protected person, he has a right to appeal directly to the Minister
of Citizenship and Immigration.
“The minister will be called
upon to balance the risk to the Canadian public if Mr. Mzite is allowed
to remain in Canada against the risk Mr. Mzite will be persecuted,
tortured or subject to cruel or unusual punishment if he is removed to
Zimbabwe.”
Johnston also noted Mzite’s health would be at risk
if he is deported. Treatment for HIV is much more advanced in Canada
than in Zimbabwe.
“I do conclude that without the kind of
treatment available here, Mr. Mzite’s infection will almost inevitably
progress much faster and lead to his death much sooner. But Mr. Mzite
will have an opportunity to be heard in the deportation process,” said
Johnston.
Johnston noted that Mzite applied himself well in
custody, taking courses in respectful relationships, substance abuse
management and peer education to help in harm reduction.
By Louise Dickson, Times Colonist
|
Calgary Catholic teachers drop charity in condom protest
Calgary
Catholic teachers have cancelled a fundraiser for AIDS relief in Africa
after a local bishop spoke out against a prominent Canadian and his
foundation’s AIDS prevention programs, which include promoting condoms.
March 28, 2009
Calgary
- Calgary Catholic teachers have cancelled a fundraiser for AIDS relief
in Africa after a local bishop spoke out against a prominent Canadian
and his foundation’s AIDS prevention programs, which include promoting
condoms.
But with the Stephen Lewis Foundation donating hundreds
of thousands of dollars annually to several church-run AIDS programs in
Africa, Lewis said that the bishop’s efforts to “excommunicate” the
charity are only going to hurt Catholics there.
“The bishop
didn’t stop to think, when you say to teachers you can’t raise money
for a foundation that is directly supporting Catholic projects in
Africa, then you are discriminating against those projects. You are
harming your own people,” Lewis said.
Teachers at the Calgary
Catholic School District have been passing the hat around among
themselves during Lent for the past five years to raise money for the
Stephen Lewis Foundation’s AIDS work in sub-Saharan Africa.
Last
year, teachers raised $45,000 through personal and matching donations,
said Calgary Catholic Teachers’ Association president David Cracknell.
But
in December, a parishioner approached Calgary Bishop Fred Henry with
questions about teachers raising funds for an organization that uses
condoms in its AIDS prevention programs, he said.
Henry met with
Cracknell to discuss the issue, then sent a letter to the teachers’
association encouraging members to focus their fundraising efforts on
other organizations in Africa.
“For me, it’s been a difficult issue,” said Cracknell.
“I
understand the commitment our teachers have toward helping people in
Africa with AIDS. I understand the fact Stephen Lewis is a very
prominent Canadian, and people are very committed to his charity. But I
also understand the bishop is our moral guide.”
In a letter to
the editor of the Calgary Herald, Henry said the Christian virtues of
chastity, abstinence and fidelity are “the most effective means of
primary HIV prevention,” and should not be pushed aside as valid
prevention options in favour of passing out condoms.
When asked
about his opposition to the Stephen Lewis Foundation, Henry said
teachers do have other options in supporting AIDS charity efforts in
Africa.
“If you have two businesses or organizations, one that
doesn’t support your values and mission statement and another that
does, which one are you going to support? I think that the answer is
obvious,” Henry told the newspaper in an e-mail.
The Calgary Catholic Teachers’ Association is evaluating whether it will organize fundraisers for Lewis’s foundation in future.
By Sarah McGinnis, www.theherald.canwest.com
|
Saskatchewan. to hire more workers to deal with HIV cases
Saskatchewan
says it will hire up to 15 new workers over the next several years to
deal with what medical officials are calling an alarming increase in
HIV cases.
March 28, 2009
Regina
-- Saskatchewan says it will hire up to 15 new workers over the next
several years to deal with what medical officials are calling an
alarming increase in HIV cases.
The province recorded 170 new
cases last year - a 40 per cent increase - which is about twice the
national average. Dr. Moira McKinnon, the province's chief medical
health officer, says more than half of the cases are women under the
age of 30 and most of the cases involve intravenous drug use.
About 65 per cent of the people are aboriginal, including two girls who are under 15. Seven babies were also born HIV positive.
"It
is alarming," she says. "We're having women turn up who have had no
pre-natal care and delivering babies and they're HIV positive. These
people aren't accessing the health system."
McKinnon says most of the new cases involve people who live in poor urban areas.
"Most
of the cases are reported in Saskatoon, Regina and Prince Albert, but
because the population is transient, it may be that they also have
community homes and they're only disclosing their urban addresses. So
we have some work to do in that area."
She says the province is also looking at bolstering testing and early treatment of HIV, the virus that leads to AIDS.
"Diagnosing people early and getting them on treatment is one of the most effective ways of preventing transmission," she says.
The Canadian Press, http://www.ctv.ca
|
Official wants to see anonymous HIV/AIDS testing
Anonymous
HIV/AIDS testing is needed on P.E.I., according to Mark Hanlon. And
it’s something the AIDS P.E.I. executive director plans to push
government for. “Right now we are the only province in Canada, yet
again, that doesn’t have anonymous testing, which is a big problem,”
said Hanlon. “If you don’t provide anonymous testing people are wary of
getting tested.”
March 30, 2009
Summerside,
PEI – Anonymous HIV/AIDS testing is needed on P.E.I., according
to Mark Hanlon. And it’s something the AIDS P.E.I. executive director
plans to push government for.
“Right now we are the
only province in Canada, yet again, that doesn’t have anonymous
testing, which is a big problem,” said Hanlon. “If you don’t provide
anonymous testing people are wary of getting tested.”
Islanders wanting to be tested for HIV/AIDS do so through their doctor
via nominal testing, where their name is on the request, or non-nominal
testing.
“People can go to their doctor, their doctor knows
who they are and there’s a code submitted to government,” Hanlon said,
explaining non-nominal testing.
With anonymous
testing, a subject doesn’t provide their name or other personal
information. Only the person tested knows they were tested and is privy
to their results.
Hanlon said AIDS P.E.I. could potentially be a test site.
“They could go in on a Monday, get tested, and on Friday, they just
come in, give a number. We have the numbers for the tests and they get
the test results back,” he added. “If they want to come back and talk
to us about a positive result or they want to talk about a negative
result and how they can avoid problems then we can do that.”
But providing anonymous testing would require government’s help.
“We need somebody on site. It doesn’t mean they have to give us any
money. They could provide a nurse,” said Hanlon. “One-day-a-week
testing and having the nurse come back later in the week to distribute
the results would be great. That way there’s no face-to-face contact
with other health professionals besides that nurse.”
The Province currently isn’t looking at introducing anonymous testing.
“We have not had a request from anyone to do it anonymously or a
proposal from anybody who would do it. We would take it on and look at
it if a request came,” said Dr. Lamont Sweet, deputy chief health
officer. “It does require that a physician be responsible for
requesting the test. So, if a physician wanted to apply to do that
anywhere, then we would have to look at that.”
Since 1985 46 people have registered as having HIV or AIDS.
Hanlon said AIDS P.E.I.’s goal is to eventually provide anonymous testing “in each corner of the province.”
“We’ve kind of had it on our radar for awhile,” he added. “It certainly would be a fantastic thing.”
Four types of HIV testing in Canada:
Nominal/name-based HIV testing
-Carried out at clinics and office of a health-care provider.
-Person ordering test knows identify of the person being tested.
-Test is ordered using the name of person being tested.
-Collection of patient information including age, gender, city of residence.
-If results are positive, person tested is legally obligated to notify public health officials of the positive test result.
Non-nominal/non-identifying HIV testing
-Similar to nominal/name-based testing on all points except the HIV
test is ordered using a code or initials of the person being tested.
Anonymous testing
-Usually available at specialized clinics, organized and supported by
public health departments and by some health-care providers.
-Person ordering test doesn’t know identity of person being tested.
-Carried out using a code. Person ordering test and lab carrying it out
don’t know who the code belongs to; only person being tested knows.
-Information such as age, gender and person’s ethnicity may be collected.
-Test results are not recorded on the health care record of person tested.
Rapid testing
Administered by health professionals at specific clinics or doctors’
offices. Results are available on-site within minutes. Currently
available in limited number of locations.
By Nancy MacPhee, http://www.journalpioneer.com
|
Patients feeling abandoned, AIDS committee says
Patients with HIV/AIDS are not getting the special care they require, the Newfoundland and Labrador AIDS Committee says.
March 31, 2009
Patients with HIV/AIDS are not getting the special care they require, the Newfoundland and Labrador AIDS Committee says.
The
only infectious disease specialist in the province recently moved away,
and out-of-province physicians now provide sporadic services every five
weeks.
Chris Pickard, executive director of the AIDS
committee, said a regular clinic has been suspended because its
nurse-practitioner is on leave until at least mid-April, and a social
worker assigned to it is available for just over a day each week.
He said people living with HIV/AIDS are feeling abandoned.
"We're
not about trying to create panic, but I think we have to make sure that
this kind of goes to the highest level, that this is a critical health
issue," Pickard told CBC News Tuesday.
"People right now don't
know what to do. They're calling into the clinic, leaving a message,
and hopefully, someone is getting back to them," said Pickard, adding
patients are optimistic that a new infectious diseases specialist will
soon be hired.
In a statement, Eastern Health said Tuesday it hopes to resume its clinics by late April.
The
clinics will continue until August, or until a new infectious disease
specialist is on duty. Until then, internal medicine specialists will
provide consultations with patients.
"Eastern Health would
like to emphasize that these are interim contingency measures, designed
to ensure care for our infectious disease patients until a full-time
specialist is in place," the authority said.
Eastern Health said it hoped to finish negotiations with a new specialist "in the very near future."
Last
week, patients and their supporters held a rally at Confederation
Building to raise awareness about the lack of regular treatment.
http://www.cbc.ca
|
On reserve or off, AIDS a disease of poverty
"A
couple of years ago, I did a documentary on AIDS in the aboriginal
community in Saskatchewan. I called it The Hidden Plague. Today, it's
not so hidden. It's a crisis."
March 30, 2009
A
couple of years ago, I did a documentary on AIDS in the aboriginal
community in Saskatchewan. I called it The Hidden Plague. Today, it's
not so hidden. It's a crisis.
When I first looked at HIV/AIDS in
the province, the problem was serious and experts expected it to
worsen. Saskatchewan now leads Canada in new cases of HIV per capita,
with double the national rate.
Last year, Saskatchewan had 174
new cases of HIV. This was up 40 per cent from the previous year, when
there were 124 new cases. The number is expected to rise this year and
next.
Even more alarming is the fact that one-quarter of the
HIV-positive babies born in Canada are in Saskatchewan. Of the 23
HIV-positive babies born across Canada last year, seven were in this
province.
These may seem like small numbers when we look at a
provincial population of about a million people, but the incidence of
AIDS is located in pockets and includes a disproportionate number of
aboriginal people.
A virulent new strain of HIV has emerged that
does not respond well to existing medication. AIDS is a long-term
disease that can take years to take hold and can be controlled for
years after that.
But this new strain takes about two years to
move from an HIV infection to full blown AIDS. This means that in the
future we will see increased costs and stresses on the medical system.
So what is the reason behind this epidemic? There is a shallow answer and a deeper one.
First,
HIV/AIDS most often is a product of a high-risk lifestyle. Intravenous
drug users and sex trade workers are the groups most at risk.
The
drug of choice in Saskatchewan for many people is injection cocaine,
and 60 per cent of the new cases were associated with injection. This
addiction can lead up to 20 needles per day.
Drug addiction and
prostitution go hand in hand. Most sex trade workers are on the street
because of a drug addiction. Many are slaves to their pimp, who keeps
them high in return for cash. HIV-positive sex trade workers pass it on
to the johns, who spread it throughout the population.
This is
reflected in the fact that almost one-third of the new HIV cases are
women under age 29, with the youngest 15 years old. Many of these women
are aboriginal.
The next question is: Why are aboriginal people most likely to be in a high-risk lifestyle?
Poverty
plays a huge part. Lack of opportunity, poor education and related
depression all play a role. But social issues are a symptom of a
greater problem.
The root of the problem lies in history and societal factors.
For most of the 20th century, generations of our people were placed in residential schools.
This
experience sapped our self-esteem, destroyed our social system and
ruined our parenting skills. The results are still with us.
Since
this is a crisis on several levels, it needs to be attacked the same
way. We need more education about the dangers of intravenous drug use;
where the problem already exists, we need to practise harm reduction.
This means more needle exchange programs and the establishment of safe
injection sites.
A lot of people see harm reduction as a stamp
of approval or encouragement, but I see it as facing reality and
treating people with respect.
Addicts are now treated as criminals. We need to move beyond a revenge mentality and treat addiction as a health issue.
The
same goes for AIDS, which many people consider a less worthy disease
because of how it is spread. In the end, it's a fatal disease just like
many others.
At one time, AIDS was seen as a disease of gay men. Now it's a disease of poverty.
It
has taken root in the inner cities in the United States, the slums of
Asia and villages in Africa. It has also found fertile ground in the
aboriginal slums of Western Canada.
The growing incidence of
AIDS is moving to a crisis and there is no end in sight. The root
problems that lead to drug use and prostitution continue to exist. Our
people are living in grinding poverty and its damage is evident.
Until governments and individual address the root causes, there will be no letup in the AIDS crisis.
By Doug Cuthand, Saskatoon StarPhoenix, The Victoria Times Colonist
|
1. Research May Support Pope's Comments Against Condom Use in Africa, Opinion Piece Says
Pope
Benedict XVI "set off a firestorm of protest" earlier this month when
he commented that condom distribution "isn't helping, and may be
worsening" the spread of HIV/AIDS in Africa, but "in truth, current
empirical evidence supports him," Edward Green, a senior research
scientist at the Harvard School of Public Health, writes in a
Washington Post opinion piece.
2. Medical Journal Slams Pope’s Condom Lie
“The
Catholic Church’s ethical opposition to birth control and support of
marital fidelity and abstinence in HIV prevention” are “well known,”
states The Lancet’s editorial, which some criticized as “virulent.”
“But, by saying that condoms exacerbate the problem of HIV, the pope
has publicly distorted scientific evidence to promote Catholic doctrine
on this issue,” said the editorial.
1. Research May Support Pope's Comments Against Condom Use in Africa, Opinion Piece Says
March 30, 2009
Pope Benedict XVI "set off a firestorm of protest" earlier this month when he commented that condom distribution "isn't helping, and may be worsening" the
spread of HIV/AIDS in Africa, but "in truth, current empirical evidence
supports him," Edward Green, a senior research scientist at the Harvard School of Public Health, writes in a Washington Post opinion piece. The condom has become a "symbol of freedom and -- along
with contraception -- female emancipation," Green writes, adding that
those who "question condom orthodoxy are accused of being against these
causes." Members of the HIV/AIDS and family planning communities "take
terrible professional risks if we side with the pope on a divisive
topic such as this," Green writes, noting that his comments "are only
about the questions of condoms working to stem the spread of AIDS in
Africa's generalized epidemics -- nowhere else."
According to
Green, several research articles published in peer-reviewed journals
such as the Lancet, Science and BMJ "have confirmed that condoms have
not worked as a primary intervention in the population-wide epidemics
of Africa." He adds that condom promotion "has worked" in countries
such as Cambodia and Thailand, where HIV is transmitted primarily
through commercial sex. "In theory, condom promotions ought to work
everywhere," Green writes, adding that this is "not what the research
in Africa shows."
Green writes that "people think they're made
safe by using condoms at least some of the time" and they "actually
engage in riskier sex." In addition, many people in Africa rarely use
condoms in stable relationships "because doing so would imply a lack of
trust," Green continues, adding that it is "those ongoing relationships
that drive Africa's worst epidemics" where most HIV cases occur in
general populations rather than high-risk groups like commercial sex
workers, men who have sex with men or injection drug users. "And in
significant proportions of African populations, people have two or more
regular sex partners who overlap in time," creating an "invisible web
of relationships through which HIV/AIDS spreads," Green writes. What
has proven effective in Africa are "[s]trategies that break up these
multiple and concurrent sexual networks -- or, in plain language,
faithful mutual monogamy or at least reduction in numbers of partners,
especially concurrent ones," Green writes, adding, "'Closed' or
faithful polygamy can work as well."
Green says that he is "not
anti-condom," adding, "All people should have full access to condoms,
and condoms should always be a backup strategy for those who will not
or cannot remain in a mutually faithful relationship." In addition,
"liberals and conservatives agree that condoms cannot address
challenges that remain critical in Africa such as cross-generational
sex, gender inequality, and an end to domestic violence, rape and
sexual coercion," Green continues, concluding, "Surely it's time to
start providing more evidence-based AIDS prevention in Africa" (Green,
Washington Post, 3/29).
http://www.kaisernetwork.org
2. Medical Journal Slams Pope’s Condom Lie
March 29, 2009

The Lancet medical journal today urged Pope Benedict XVI
to retract or correct the public record regarding his comments about the utility of condoms in fighting HIV in Africa.
RELATED ARTICLES
More Condom Lies From the Pope
France, Germany, U.N. Denounce Pope’s Comments
Vatican Defends Pope’s Condom Lie
During
the pope’s first trip to Africa earlier this month, he said HIV is a
“tragedy that cannot be overcome by money alone, that cannot be
overcome through the distribution of condoms, which can even increase
the problem.”
“The Catholic Church’s ethical opposition to
birth control and support of marital fidelity and abstinence in HIV
prevention” are “well known,” states The Lancet’s editorial, which some
criticized as “virulent.” “But, by saying that condoms exacerbate the
problem of HIV, the pope has publicly distorted scientific evidence to
promote Catholic doctrine on this issue,” said the editorial.
“The governments of Germany, France, and Belgium released statements
criticizing the pope’s views,” as did aid agencies, The Lancet said.
“The Joint United Nations Programme on HIV/AIDS, the U.N. Population
Fund, and the World Health Organization released an updated position
statement on HIV prevention and condoms, which said that “the male
latex condom is the single most efficient, available technology to
reduce the sexual transmission of HIV.”
“Whether the pope’s
error was due to ignorance or a deliberate attempt to manipulate
science to support Catholic ideology is unclear,” said the editorial.
“When any influential person, be it a religious or political figure,
makes a false scientific statement that could be devastating to the
health of millions of people, they should retract or correct the public
record. Anything less from Pope Benedict would be an immense disservice
to the public and health advocates, including many thousands of
Catholics, who work tirelessly to try and prevent the spread of HIV and
AIDS worldwide.”
The editorial is titled “Redemption for the Pope?”
http://www.hivplusmag.com
|
Newly Created Institute 'Rare Bit of Good News' In HIV/AIDS Vaccine Efforts, Editorial Says
The
Providence Journal says that "[p]hilanthropists everywhere are cutting
back on or suspending charitable contributions," but a 2007 visit to
South Africa "convinced [Ragon] there was no time to waste." Ragon's
"inspiring example may encourage others leery of giving."
March 30, 2009
Although former President George W. Bush "made an ambitious new
commitment to the global fight against AIDS," and Congress in 2008
"authorized billions in new spending," lawmakers and philanthropists
"will retreat" as the current economic recession continues, a Providence Journal editorial says. So it "comes as a rare bit of good news" that Phillip Ragon -- founder of the software company InterSystems Corp. -- is " giving $100 million of his own to the quest for an AIDS vaccine," the Journal
says. Ragon "will allocate his gift in $10 million annual installments
over 10 years" to the newly formed Ragon Institute -- a collaboration between Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University -- the Journal continues, adding that the three groups will "join in an effort to find new approaches" to an HIV/AIDS vaccine.
A
vaccine for HIV/AIDS "has been the holy grail of AIDS research" but has
proven difficult to find because the disease "has shown an uncanny
ability to alter its makeup and elude destruction," the editorial says.
The Ragon Institute aims "to find new ways of deploying the immune
system against a variety of diseases, not just AIDS," the Journal
writes, adding that the "hope is that, for example, MIT engineers can
lend new perspectives to the medical doctors, biologists and others who
have already spent years tilling this hard soil." The Journal says that
"[p]hilanthropists everywhere are cutting back on or suspending
charitable contributions," but a 2007 visit to South Africa "convinced
[Ragon] there was no time to waste." Ragon's "inspiring example may
encourage others leery of giving. May the Ragon Institute succeed," the
editorial concludes (Providence Journal, 3/27).
http://www.kaisernetwork.org
|
Dying, and Alone, in Myanmar
The
most heartbreaking moment for doctors and nurses treating people with
HIV/AIDS in Myanmar is the arrival of a new patient. Running short of
funds and medications, clinics have started turning dying people away.
March 31, 2009
International Herald Tribune
A 49-year-old man in the advanced stages of H.I.V. has not told friends
about his situation because of the social stigma attached to the
disease. "The worst thing for me is the loneliness," he said. Two weeks
after this photograph was taken, he died. More Photos >
Bangkok - The most heartbreaking moment
for doctors and nurses treating people with HIV/AIDS in Myanmar is
the arrival of a new patient. Running short of funds and medications,
clinics have started turning dying people away.
“They continue to knock on
our doors, even though we can’t take in most of them,” said Joe
Belliveau, operations manager of the international aid group Médecins
Sans Frontières.
The 23 clinics run by the group, also known
as Doctors Without Borders, are the primary dispensers in Myanmar of
the antiretroviral drugs that can prolong the lives of those infected
with HIV., the virus that leads to AIDS. So most of the people it
cannot treat are likely to die.
The people of Myanmar, a country
that seems to have been marked for suffering, receive little foreign
assistance — the country ranks among the lowest per capita for such aid
in the world. The same is true for assistance for people with HIV/AIDS.
Médecins Sans Frontières estimates that 240,000 people are
currently infected with H.I.V. in Myanmar and that 76,000 are in urgent
need of antiretroviral drugs. Every year, about 25,000 people with the
virus die.
The group’s clinics have been providing 11,000 people
with the antiretroviral drugs that keep them alive. The longer they
live, the more treatment they need. The group says it is unable to
increase its budget there without taking money away from people in need
elsewhere.
Last year it made the difficult decision to stop
accepting any new patients in order to continue treating the old ones.
It has opened its doors a little bit this year, accepting 3,000 new
patients, still a fraction of those in need.
“When we stopped
last July it was devastating for the staff,“ Belliveau said. “They
couldn’t even treat the ones dying on their doorsteps.”
This
year, the United Nations-backed Global Fund To Fight AIDS, Tuberculosis
and Malaria has applied for government permits to bring antiretroviral
drugs into Myanmar, and the number of people receiving treatment is
likely to rise.
But that will only be one step. Fewer than 20
percent of those who need the drugs receive them, either from
international groups or, in very small amounts, from the government,
Médecins Sans Frontières said in a report released in November.
When
a photographer visited a clinic a few months ago, he found anguish and
fatalism among the people who had not received the drugs.
“I can
only live longer if I have ART,” said one 28-year-old woman, referring
to the antiretroviral treatment she needs. “Most of the money and
possessions I had are already gone. My family sends me food from the
village, but they cannot support my treatment. If I get ART I will be
able to live, if not, I will die.”
In one room the
photographer found a 49-year-old man, gaunt and weak, sitting on the
side of a bed. He had no family, and because of the stigma of the
disease he was ashamed to tell his friends or co-workers about it.
“The worst thing for me is the loneliness,” he said.Two weeks after his picture was taken, he was dead.
http://global.nytimes.com/
|
Researchers boost immune system against cancers, HIV/AIDS with spirulina
Extracts
of a local lake-weed, spirulina, have shown huge potentials in treating
cancers, Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency
Syndrome (AIDS), and malnutrition by boosting the immune system.
March 26, 2009
Extracts of a local lake-weed, spirulina, have shown huge potentials in
treating cancers, Human Immuno-deficiency Virus (HIV)/Acquired Immune
Deficiency Syndrome (AIDS), and malnutrition by boosting the immune
system. CHUKWUMA MUANYA reports.
THEY float on water. They are blue-green filamentous algae. Blue-green
algae are aquatic plants that manufacture their own food. They grow in
abundance on Lake Chad. Though often weeded out, recent studies have
found the algae, spirulina, useful in treating cancers and Human
Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome
(AIDS), as well as boosting food production and immune system.
Spirulina are common articles of trade on the streets of Maiduguri,
Borno State. Its use from Lake Chad dates as far back as the 9th
century Kanem Empire. It is dried into cakes called Dih�, which are
used to make broths for meals, and also sold in markets. The Spirulina
is harvested from small lakes and ponds around Lake Chad.
It was reported that in 1976, an American, Larry Switzer, proposed to
the Nigerian Government to use oil money to finance farms along the
shores of Lake Chad to feed the country's growing urban masses. But the
novelty of algae, lack of interest in food production, and a political
coup doomed this plan. The lesson learnt by Switzer was to develop the
technology and a consumer market in the United States first, and then
apply it to the Third World.
Undeterred, Switzer later founded Proteus Corporation and the Earthrise
Company, which built the first spirulina farm in California, United
States, the forerunner to Earthrise Farms. Earthrise introduced
spirulina in 1979.
A study reported in Nutrition and Cancer that was conducted among
tobacco chewers in India reported a complete regression of
pre-cancerous mouth lesions in 45 per cent of subjects who were given
extracts of spirulina for 12 months. This was the first human study
using spirulina as a cancer therapy.
The United Nations World Health Organisation (WHO) in Geneva has
confirmed: "Spirulina represents an interesting food for multiple
reasons, and it is able to be administered to children without any
risk. We at WHO consider it a very suitable food."
According to a scientific review from Latin America, spirulina has a
vast array of beneficial properties. It has been shown to be effective
in the treatment of allergies, anemia, cancer, high cholesterol,
elevated blood sugar, viral infections, inflammatory conditions, liver
damage, immuno -deficiency, cardiovascular diseases, and other
conditions.
Mark Stengler in his book, "A Natural Physician's Healing Therapies",
wrote: "More than 100 published scientific references help support the
case for the health benefits of spirulina. Some studies demonstrate
that spirulina seems to possess anticancer effects and antiviral
properties. Also, animal studies show that it is a powerful tonic for
the immune system."
Donald R. Yance Jr. in his book, "Herbal Medicine Healing Cancer"
wrote: "Spirulina's pure protein, which arrives within the context of
massive amounts of beta-carotene, chlorophyll, fatty-acid
-gamma-linolenic acid (GLA), and other nutrients, is especially helpful
to those who are overweight, diabetic, hypoglycemic, or suffering from
cancer, arthritis, or other degenerative diseases. "
An advocate of natural medicine and a Consultant Homeopath at the
Global Foundation for Integrative Medicine in Santa Fe New Mexico,
United States, Prof. Osmond Ifeanyi Onyeka, told The Guardian that
spirulina contains the most remarkable concentration of nutrients known
in any food, plant, grain or herb.
"Spirulina has the highest protein food which is over 60 per cent of
all the digestible vegetable protein. Most notably, spirulina is 65 to
71 per cent complete protein, with all essential amino acids in perfect
balance. In comparison, beef is only 22 per cent protein. It also has
the highest concentration of beta carotene, vitamin B-12, iron and
trace minerals and the rare essential fatty acid GLA. These surely make
Spirulina an incredible whole food alternative to the isolated vitamin
and minerals," Onyeka said.
He added that spirulina is overloaded with unique phyto-nutrients like
phycocyanin, polysaccharides and sulphurlipids that not only enhance
the immune system, but also reduces the risks of infection, cancer and
auto immune diseases.
"Spirulina is rich in natural carotenoid antioxidants that promote
cellular health and lessen the risk of cancer. It also has cleansing
chlorophyll which helps detoxify bodies that are always prone to
present pollution," Onyeka said.
He further explained: "Scientifically explained the most important
dictate of our body's metabolism is to support our immune system. When
our immune system is stressed or is suffering, it draws on our body's
metabolic energy. People with immune system imbalance often feel
chronic fatigue and low energy.
"Both scientific research and the experience of thousands of consumers
indicate that Spirulina is an immune regulating food. Small amounts can
help balance and stabilise the immune system, freeing up more of our
metabolic energy for vitality, healing and assimilation of nutrients.
It enhances the body's cellular communication process and also has the
ability to read and repair DNA, like a kind of cellular tune up. This
is why individuals taking Spirulina often report they have more energy
levels."
Spirulina is widely available as both an animal and a human dietary
supplement in powder, tablet and flake form, and is broadly used due to
its nutritional profile. It has been shown to be a complete protein
(albeit with lesser amounts of certain amino acids), high in essential
fatty acids, vitamins, minerals, photosynthetic pigments including
chlorophyll, polysaccharides and glycolipids.
A senior lecturer at the Department of Parasitology and Entomology,
Nnamdi Azikiwe University (NAU) Awka, Anambra State, Dr. Abiodun Nwora
Ozumba, told The Guardian: "It is unfortunate that the country is
sitting on a goldmine and is not doing anything about it. The best
spirulina in the whole world grows at our backyard on Lake Chad. It is
sold for almost nothing on the streets of Maiduguri. Westerners come
here, buy it for little or nothing, go back, develop it into
supplements, and ship it back to us to buy.
"Spirulina is 20 times more productive as a protein source than any
other food. It could be grown with unused land and water. It was
possible to cultivate a pure culture on a large scale in many places
around the world. Scientists discovered spirulina was a safe food, had
been consumed for hundreds of years by traditional peoples, and showed
promising nutritional, and even therapeutic, health benefits.
"If this blue-green algae were cultivated and consumed by millions of
people, it would have tremendous benefits, especially for the world's
children and our planet's future. Spirulina seemed to be the solution
we needed. However, it was all theory, it had not been done yet."
Most cultivated spirulina is produced in open-channel raceway ponds,
with paddle-wheels used to agitate the water. The largest commercial
producers of spirulina are located in the United States, Thailand,
India, Taiwan, China, Pakistan and Myanmar (the Burma).
Phytochemical analysis indicates that spirulina contains an unusually
high amount of protein, between 55 per cent and 77 per cent by dry
weight, depending upon the source. It is a complete protein, containing
all essential amino acids, though with reduced amounts of methionine,
cysteine, and lysine when compared to the proteins of meat, eggs, and
milk. It is, however, superior to typical plant protein, such as that
from legumes.
Spirulina is rich in GLA, and also provides alpha-linolenic acid (ALA),
linoleic acid (LA), stearidonic acid (SDA), eicosapentaenoic acid
(EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA).
Spirulina contains vitamin B1 (thiamine), B2 (riboflavin), B3
(nicotinamide), B6 (pyridoxine), B9 (folic acid), vitamin C, vitamin D,
and vitamin E.
The bioavailability of vitamin B12 in Spirulina is in dispute. Several
biological essays have been used to test for the presence of vitamin
B12. The most popular is the United States Pharmacopeia method using
the Lactobacillus leichmannii assay. Studies using this method have
shown Spirulina to be a minimal source of bioavailable vitamin B12.
However, this assay does not differentiate between true B12 (cobalamin)
and similar compounds (corrinoids) that cannot be used in human
metabolism.
Cyanotech, a grower of spirulina, claims to have done a more recent
assay, which has shown spirulina to be a significant source of
cobalamin. However, the assay is not published for scientific review
and so the validity of this assay is in doubt. The American Dietetic
Association and Dietitians of Canada in their position paper on
vegetarian diets state that spirulina cannot be counted on as a
reliable source of active vitamin B12.
Tests done on Australian grown spirulina by the Australian Government
Analytical Laboratory (AGAL) show Vitamin B12 (cobalamin) levels of
659.1 ug / per100g. A one gram tablet could provide more than three
times the recommended daily intake of B12.
Previous studies indicate that spirulina is a rich source of potassium,
and also contains calcium, chromium, copper, iron, magnesium,
manganese, phosphorus, selenium, sodium, and zinc.
Studies also found that spirulina contained many pigments including
chlorophyll-a, xanthophyll, beta-carotene, echinenone, myxoxanthophyll,
zeaxanthin, canthaxanthin, diatoxanthin, 3'-hydroxyechinenone,
beta-cryptoxanthin, oscillaxanthin, plus the phycobiliproteins
c-phycocyanin and allophycocyanin.
Despite existing research supporting Spirulina's health and healing
properties, detractors claim that these are frequently overstated by
Spirulina advocates. Conversely, Spirulina advocates have accused
health food detractors of dismissing all such claims without
acknowledging this research.
Two online publications exemplify these opposing positions,
respectively: Wellness Letter on Blue Green Algae, and Superfoods For
Optimum Health: Chlorella and Spirulina. Many positive claims are based
on research done on individual nutrients that Spirulina contains, such
as GLA, various antioxidants, among others, rather than on direct
research using Spirulina. What follows is research on the health and
healing effects of Spirulina.
In vitro research (example, studying cells in a petri dish) may suggest
the possibility of similar results in humans but, due to the
drastically different conditions of the research, provides only hints
at the potential for human effects.
Animal research can also provide evidence of potential human effects.
Human research focuses on actual effects in humans, however, the
validity and reliability of the research depends on the design of the
study. The strongest evidence comes from well-designed and controlled
clinical trials, which are one type of human research study.
Spirulina extract has been shown to inhibit HIV replication in human
T-cells, peripheral blood mononuclear cells (PBMC), and Langerhans
cells.
Other studies indicate that spirulina helps prevent heart damage caused
by chemotherapy using Doxorubicin, without interfering with its
anti-tumor activity. Spirulina reduces the severity of strokes and
improves recovery of movement after a stroke; reverses age-related
declines in memory and learning; and prevents and treats hay fever.
Spirulina is effective for the clinical improvement of melanosis and
keratosis due to chronic arsenic poisoning; improves weight-gain and
corrects anemia in both HIV-infected and HIV-negative undernourished
children; and protects against hay fever.
A 2007 study found that 36 volunteers taking 4.5 grams of spirulina per
day, over a six week period, exhibited significant changes in
cholesterol and blood pressure: (1) lowered total cholesterol; (2)
increased High Density Lipo-protein (HDL) cholesterol; (3) lowered
triglycerides; and (4) lowered systolic and diastolic blood pressure.
However, as this study did not contain a control group, researchers can
not be confident that the changes observed are due totally - or even
partially - to the effects of the Spirulina Maxima as opposed to other
confounding variables (that is, history effects, maturation effects,
demand characteristics).
Until recently, much spirulina was certified organic. In 2002, the
United States Department of Agriculture's National Organic Standards
Board voted to disallow the use of Chilean nitrate. They granted a
three-year window to spirulina producers, which expired in 2006. As a
result, leading spirulina manufacturers have stopped labelling their
spirulina as organic, citing safety concerns of nitrate alternatives.
The United Nations World Food Conference in 1974 lauded Spirulina as
the 'best food for the future'. Recognising the inherent potential of
Spirulina in the sustainable development agenda, several Member States
of the United Nations came together to form an intergovernmental
organisation by the name of the Intergovernmental Institution for the
Use of Micro-algae Spirulina Against Malnutrition (IMSAM). IIMSAM
aspires to build a consensus to make Spirulina a key driver to
eradicate malnutrition, achieve food security and bridge the health
divide throughout the world.
Spirulina has been proposed by the United States National Aeronautic
Space Agency (NASA), and the European Space Agency (EPA); as one of the
primary foods to be cultivated during long-term space missions.
Switzer, wrote about his hope for a breakthrough in food production:
"It had to be more productive than conventional agriculture...
adaptable to different climates and cultures... appropriate
ecologically, economically and socially... independent of the vested
interests in world food production and distribution... capable of
relying on renewable energy and waste or abundant raw material
resources. It would have to represent a major expansion of the
photosynthetic energy base that supports all life on Earth.
"Finally, it would have to radically improve the supply, distribution
and consumption of essential protein to millions of pregnant and
nursing mothers, infants and children. It is absolutely critical to
provide nutrition to the deprived embryos and infants of the world to
preserve the precious creative genius that is waiting to be released
from each fully developed human mind."
http://www.ngrguardiannews.com
|
Tuberculosis: HIV Infection Sharply Raises Risk for TB, Report Says
One-quarter
of all deaths from tuberculosis are in patients also infected with the
AIDS virus, twice as many as previously thought, the World Health
Organization said last week.
March 30, 2009
One-quarter of all deaths from tuberculosis are in patients also infected with the AIDS virus, twice as many as previously thought, the World Health Organization said last week.
Health Guide: AIDS | Disseminated Tuberculosis
In its annual Global TB Control report, the organization said that being infected with the
virus can increase the risk of developing tuberculosis by 20 times.
Up to one-third of the world’s people are infected with tuberculosis
bacteria, but the infection usually is dormant unless the immune system
is weakened by malnutrition, alcoholism, drug abuse, immunosuppressive drugs, AIDS or other causes.
About 9.3 million people develop TB each year, the report said, and 1.8
million die. About 456,000 are counted as AIDS deaths because the
victims have both.
The
apparent jump in dual cases is not because of a leap in infections but
because African countries are doing a better job of testing patients
for both diseases.
Curing a typical tuberculosis infection requires taking four different antibiotics daily for six months. But resistance to those drugs is a growing
problem. About 500,000 people now have multi-drug-resistant
tuberculosis, which is common in Eastern Europe and in the countries of
the former Soviet Union, as well as in China and India. Fewer than 1
percent of them are receiving care that meets W.H.O. standards, which
includes daily injections of toxic drugs for two years.
More than 50 countries have reported cases of XDR-TB, the extensively
drug-resistant form. Many of those patients die quickly despite
treatment.
Doctors Without Borders said after the report’s release that TB was “spiraling out of control.”
By Donald
G. McNeil Jr., http://www.nytimes.com
|
HIV/Hep C Coinfection
1. HIV Before Hep C? Be Careful!
Research indicates that men who acquire hepatitis after HIV infection have worse chances with liver disease.
2. Hepatitis C has no impact on CD4 cell recovery in patients taking HIV treatment
Patients
co-infected with HIV and hepatitis C virus whose HIV treatment is
suppressing their viral load to undetectable levels have comparable CD4
cell count increases to those seen in patients who are only infected
with HIV, investigators report in the April 15th edition of the Journal
of Acquired Immune Deficiency Syndromes.
1. HIV Before Hep C? Be Careful!
March 30, 2009

At
a San Francisco forum titled “Could You Survive HIV Only to Die From
Hepatitis C?” presenters talked about the growing number of hepatitis C
virus infections found among HIV-positive men who have sex with men.
The Conant Foundation’s Dr. Marcus Conant said outbreaks of hepatitis C
apparently linked to sexual activity began appearing among MSM in
London and continental European cities around 2002. University of
California, San Francisco, researcher Dr. Brad Hare said 42% of
HIV-positive men in UCSF’s Positive Health Program now have HCV.
Recent acute HCV coinfections among HIV-positive men appear to
represent “a new 21st century clinical syndrome,” said Dr. Daniel
Fierer of New York’s Mount Sinai School of Medicine. Previous studies
of monogamous HIV-negative heterosexuals indicated a sexual HCV
transmission rate of less than 5% -- suggesting sexual transmission is
rare. Though specifics vary among studies, the recent acute HCV
outbreaks among MSM have been linked to unprotected anal sex, fisting,
group sex, sharing sex toys, coinfection with other STDs, and the use
of noninjected recreational drugs.
The process whereby HCV destroys the liver typically takes years or
decades. But Fierer said his analysis of a small but growing number of
coinfected MSM in New York suggests acute HCV infection in a person
already infected with HIV leads to unusually rapid liver damage. He has
theorized that existing HIV infection may predispose patients to
accelerated liver fibrosis if they are subsequently infected with HCV.
This rapid disease progression is not common in coinfected
injection-drug users, who typically acquire HCV before HIV.
Fierer’s findings are controversial, since U.K. and European
researchers have not reported similar rapid disease progression.
However, they have tended to use noninvasive methods, not the more
accurate liver biopsies employed by Fierer’s team, to evaluate liver
damage.
Fierer added the good news that if HCV treatment is begun during the
acute phase of infection, there is a good chance of both eliminating
HCV and improving liver damage.
http://www.hivplusmag.com
2. Hepatitis C has no impact on CD4 cell recovery in patients taking HIV treatment
March 27, 2009
Patients co-infected with HIV and hepatitis C virus whose HIV treatment
is suppressing their viral load to undetectable levels have comparable
CD4 cell count increases to those seen in patients who are only
infected with HIV, investigators report in the April 15th edition of
the Journal of Acquired Immune Deficiency Syndromes.
It is estimated that there are 2 million HIV-positive individuals
co-infected with hepatitis C virus in the European region. Earlier
research has provided conflicting information on the effect of
co-infection on CD4 cell recovery in individuals taking HIV treatment.
Differences in adherence to HIV treatment or the potency of
antiretroviral regimens were a potential limitation of this studies.
Furthermore, they defined hepatitis C-co-infection as the presence of
antibodies to the virus and did not investigate the influence of either
hepatitis C replication or genotype.
Investigators from the EuroSIDA cohort therefore designed a prospective
study to assess the influence of chronic hepatitis C-co-infection and
genotype on CD4 cell recovery in HIV-positive patients whose HIV
treatment achieved and sustained the suppression of viral load to
undetectable levels (below 50 copies/ml).
Patients
with antibodies to hepatitis C virus and at least two consecutive
undetectable HIV viral loads after starting HIV treatment were eligible
for inclusion in the study. The investigators calculated the annual
change in CD4 cell count for these patients and then compared them to
those observed in patients only infected with HIV whose antiretroviral
therapy had suppressed viral load to undetectable. Further analyses
were then performed to determine the impact of hepatitis C genotype and
replication on CD4 cell recovery.
A
total of 4208 patients were included in the investigators’ analyses.
The first of these showed that there was no significant difference in
the annual CD4 cell count increase seen in the co-infected patients (36
cells/mm3, 95% CI, 27.2-43.9) and the patients only infected with HIV
(38 cells/mm3, 95% CI, 34.8-41.9).
These results did not change when the investigators adjusted for
hepatitis C genotype. Nor were they altered by adjusting for
nucleos(t)ide combinations, third antiretroviral drug, age, time since
starting antiretroviral therapy, time to initial viral suppression, or
whether an individual was treatment-naïve or treatment experienced when
they started combination HIV therapy.
Taking into account ongoing hepatitis C replication did not
significantly affect the results. Nor did the hepatitis C genotype
influence CD4 cell recovery in these patients with ongoing hepatitis C
replication. Finally the investigators compared changes in CD4 cell
counts according to co-infected patients’ hepatitis C viral load. This
showed that although annual CD4 cell gains (43 cell/mm3) were higher
amongst patients with a hepatitis C viral load below 1 million iu/ml
than those with a hepatitis C viral load above this level (35
cells/mm3), the difference was not significant (p = 0.43).
“In this large prospective cohort study, we provide evidence that
hepatitis C virus coinfection does not influence the CD4 cell recovery
in HIV-1-infected patients who are persistently maximally HIV
suppressed…compared with HIV-monoinfected patients”, write the
investigators.
Nor did they find any differences in CD4 cell gain when comparing
patients who were hepatitis C “viremic vs. aviremic patients with
hepatitis C virus antibodies, and between distinct hepatitis C virus
genotypes among viremic patients.”
They
do however conclude that co-infected patients may benefit from starting
HIV treatment earlier than otherwise recommended “because studies have
shown that combination antiretroviral therapy may slow fibrosis
progression.” They also note the benefits of hepatitis C treatment for
co-infected patients as “hepatitis C virus eradication will lower the
risk of hepatotoxicity induced by antiretroviral drugs and progression
of liver disease.”
Reference
Peters, L. et al. Hepatitis C virus coinfection does not influence the
CD4 cell recovery in HIV-1-infected patients with maximum virologic
suppression. J Acquir Immune Defic Syndr 50: 457-63, 2009.
By Michael Carter, http://www.aidsmap.com
|
New Drug May Boost HIV Treatment Effectiveness
The
addition of an experimental amino acid to a standard HIV drug regimen
may be all that’s necessary for people struggling to keep their viral
loads undetectable, according to a study published in The Journal of
Immunology and reported by EurekAlert.
April 1, 2009
The addition of an experimental amino acid to a standard HIV drug
regimen may be all that’s necessary for people struggling to keep their
viral loads undetectable, according to a study published in The Journal of Immunology and reported by EurekAlert.
Despite
the potency of modern antiretroviral (ARV) treatment, it still fails to
keep HIV completely under control in roughly 10 to 20 percent of people
beginning treatment for the first time. Researchers have experimented
with adding additional ARV drugs to typical regimens, but this
strategy—called treatment intensification—comes with a good chance of
additional side effects and without a guarantee of increased
effectiveness.
Now,
Adriano Boasso, PhD, from the Imperial College London, and his
colleagues report that a modified amino acid called D-1mT increased the
effectiveness of ARV treatment in monkeys infected with simian
immunodeficiency virus (SIV)—the monkey version of HIV.
Boasso’s
team originally theorized that D-1mT would help control SIV in monkeys
regardless of whether they were given ARV treatment. This is because
D-1mT is able to block an enzyme called IDO that HIV and SIV use to
suppress the immune system’s attempts to control the viruses. Boasso’s
team found that D-1mT had no effect at all in monkeys who were not on
ARV therapy. To their surprise, however, D-1mT did help four of six
monkeys who were on ARV therapy but had uncontrolled virus levels.
“The
effect D-1mT seemed to have on viral load was really encouraging, but
it was a surprise to us—we didn’t expect D-1mT to work only in
[monkeys] that were already being treated with [ARVs],” Boasso said.
“It seems that D-1mT synergizes with [ARVs], and we would really like
to find out how this works.”
The
authors intend to explore this effect further and to evaluate the
safety of D-1mT, which is in a Phase I human study as a cancer
treatment.
http://www.poz.com
|
Protein Grown in Tobacco Plant Could Result in Low-Cost Microbicide, Study Says
Tobacco
has claimed countless lives since people first realized they could chew
or smoke it. But researchers have found a use for tobacco that could
potentially save lives. A study in Kentucky has shown that a protein
found within tobacco plants may be able to inhibit HIV, and that it may
be particularly well suited for development in a vaginal microbicide
gel. Adding to the protein's appeal is that it apparently can be
produced in large amounts cheaply, which may make it especially
alluring for use in developing countries.
April 1, 2009
Researchers
on Monday announced that tobacco plants in Kentucky have been used in a
study to develop a low-cost drug that inhibits HIV, providing hope for
the eventual development of a vaginal microbicide, the Louisville Courier-Journal reports (Kenning, Louisville Courier-Journal, 3/31). The study,
published Tuesday in the Proceedings of the National Academy of
Sciences, was a collaborative effort between scientists at the Owensboro Cancer Research Program; the National Cancer Institute; Kentucky-based biotech companies Intrucept BiomedicineKentucky Bioprocessing; and researchers at Duke University and the University of London (Adkins, Business First of Louisville, 3/30).
According
to the Courier-Journal, the researchers used a manufacturing process
that utilized an existing protein called Giffithsin, which can inhibit
HIV transmission during sexual activity. Kenneth Palmer, lead
researcher and senior scientist at the University of Louisville,
said that he used a method to grow large amounts of the protein in a
relative of the tobacco plant at a low cost, producing 500,000 doses
from a 5,000 square-foot greenhouse, the Courier-Journal reports.
Palmer said the process resulted in a product that could be more
effective than previous microbicide efforts.
According
to Palmer, many scientists are pursuing HIV prevention methods, mostly
in gel forms that attack the virus, but some have had side effects and
were expensive to produce. The Courier-Journal reports that Palmer's
product did not appear to cause inflammation in users and that a
vaginal gel made through the process "could potentially cost just a few
cents." Palmer said that the end-product, likely a gel, could be
available as early as 2015 if clinical trials are successful
(Louisville Courier-Journal, 3/31). He estimated that "tens of
millions" of dollars would be needed to continue the project through
the third phase of clinical testing. Donald Miller, director of the James Graham Brown Cancer Center,
said that international donors might be interested in assisting in
funding the research. Miller said the new study is a "very important
piece of work." He added, "We think this is a validation of our belief
that this is going to be a very viable, cost-effective way to produce
new drugs" (Business First of Louisville, 3/30). According to Palmer,
condoms are the only product currently available and "they're obviously
not enthusiastically embraced by all users." He added that there is "a
big need for an effective, female-controlled intervention to protect
from HIV" (Louisville Courier-Journal, 3/31).
www.kaisernetwork.org
|
Earlier Antiretroviral Treatment Could Reduce Risk of Death in HIV-Positive People, Study Finds
For
the second analysis, the researchers studied 9,000 patients, comparing
those who began treatment six months within receiving a CD4 count of
500 or greater with those who delayed starting treatment until their
CD4 count was below 500. The researchers found that there was a 94%
higher risk of death among patients who delayed treatment
April 02, 2009
A
study published Wednesday in the New England Journal of Medicine
suggests that starting HIV-positive people on antiretroviral treatment
earlier than what current guidelines recommend could reduce the risk of
death, the Wall Street Journal's "Health Blog" reports (Goldstein, "Health Blog," Wall Street Journal, 4/1).
Researchers in two separate analyses examined the medical records of
about 17,000 HIV-positive people (Waters, Bloomberg,
4/1). They looked at participants' CD4+ T cell count, starting with
8,000 participants in the first analysis. The researchers compared
patients who began antiretroviral treatment within six months of
receiving a CD4 count between 351 and 500 with those who delayed
starting treatment until after their CD4 count was 350 or less. The
patients that delayed treatment had a 69% higher risk of death during
the follow-up period.
For
the second analysis, the researchers studied 9,000 patients, comparing
those who began treatment six months within receiving a CD4 count of
500 or greater with those who delayed starting treatment until their
CD4 count was below 500. The researchers found that there was a 94%
higher risk of death among patients who delayed treatment ("Health
Blog," Wall Street Journal, 4/1). Bloomberg reports that the study adds
to growing support for changing current guidelines, which recommend
starting HIV-positive people on antiretroviral treatment when CD4
counts fall below 350. Current guidelines also say that doctors can
decide on an individual basis whether patients with CD4 counts above
350 should begin treatment. For several years, doctors and patients
have struggled with when to begin antiretroviral treatment, which can
have significant side effects such as nausea, stomach issues, changes
in blood fat levels and altered mental processes, Bloomberg reports.
Reaction
The study adds "weight to a growing body of research that suggests
treating HIV at earlier stages can help save lives," Bloomberg reports.
"The drugs are now safer and the evidence mounting from our data and
other data suggests it makes sense to start therapy earlier," Richard
Moore, study author and professor of medicine at Johns Hopkins Bloomberg School of Public Health, said. Jason Kantor -- an analyst with RBC Capital Markets in San Francisco -- said the study's findings are already known to many
doctors but that they still are likely to spark increased use of
antiretroviral treatment. Brad Hare, medical director of the University
of California-San Francisco's Positive Health Program at San Francisco General Hospital, said the study provides "a
scientific foundation for a practice that a lot of patients and doctors
have already been doing, namely starting medications earlier."
Harvard Medical School researchers Paul Sax and Lindsey Baden write in an accompanying
editorial that the findings cannot be considered conclusive because
researchers did not randomly assign patients to begin treatment at
different stages but analyzed patient records, Bloomberg reports. The
editorial says, "The supportive evidence for the benefits of earlier
therapy continues to increase," although the study did not "provide
definitive proof that we should start antiretroviral therapy in all"
HIV-positive patients (Bloomberg, 4/1). Sax and Baden also write that
the participants who began treatment earlier might have differed from
those who waited in ways that improved survival rates and were
independent of when they initiated therapy. To address this,
researchers should randomly assign patients to begin therapy earlier or
later and determine which group fares better, the editorial says,
noting that at least three such studies are ongoing or planned ("Health
Blog," Wall Street Journal, 4/1). Hare said that the study will spark a
discussion into changing current guidelines on when to begin treatment
and whether the government should fund a randomized clinical trial. The
study was sponsored by two federal agencies, including NIH (Bloomberg, 4/1).
The study is available online. The accompanying editorial also is available online.
http://www.kaisernetwork.org
|
Resistant HIV Even More Dangerous
Drug-resistant
forms of HIV can be spread between individuals who have not received
antiretroviral treatment, according to Deenan Pillay of University
College, London, and the Health Protection Agency, speaking at the
Society for General Microbiology meeting in Harrogate, England.
Drug-resistant
forms of HIV can be spread between individuals who have not received
antiretroviral treatment, according to Deenan Pillay of University
College, London, and the Health Protection Agency, speaking at the
Society for General Microbiology meeting in Harrogate, England.
Antiretroviral therapy is a major advance in the treatment of HIV, and
there are currently over 25 drugs available. It is known that the virus
can mutate, reducing its susceptibility to treatment, and that these
resistant viruses can be transmitted between individuals. Professor
Pillay found that drug resistant viruses could also circulate between
individuals who have not received antiretroviral drug treatments.
"Our findings show that assuming that drug-resistant HIV was only
passed on from individuals receiving drug treatment may mean the number
and size of the reservoirs of drug resistant virus…have been
underestimated," said Pillay. "Our results indicate that although the
incidence of drug resistance has been declining, this might not
continue -- which could have implications for planning and management
of treatment programs".
http://www.hivplusmag.com
|
Link: Visit the March 2009 Visual AIDS Web Gallery

"Untitled," 1993; Bruce Wm. Witsiepe
Visit the March 2009 Visual AIDS Web Gallery to view our latest collection of art by HIV-positive artists!
This month's gallery, entitled "Liminal:Subliminal: Sublime," is curated by Bernard Leibov.
|
|
|